Supplementary Table S2 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study

crossref(2024)

引用 0|浏览28
暂无评分
摘要
Supplementary Table 2. Representativeness of Study Participants
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要